Status:
UNKNOWN
Electrostimulation of Skeletal Muscles in Patients Listed for a Heart Transplant
Lead Sponsor:
Research Institute for Complex Problems of Cardiovascular Diseases, Russia
Conditions:
Sarcopenia
Heart Failure, Systolic
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Heart transplantation is the best way to treat terminal heart failure, which can improve the quality and life expectancy of patients, as well as contribute to their social and labor rehabilitation. Ac...
Eligibility Criteria
Inclusion
- Patients with end-stage heart disease, listed for heart transplantation
- already received standard treatment based on patient condition
- are receiving guideline recommended pharmacologic therapy
- able to follow protocol procedures
- assigned the informed consent
- do not regularly exercise (10 minutes or more a day of exercise most days of the week for the past week).
Exclusion
- UNOS 1a or 1b patients
- already receive NMES at femoris area in last 6 weeks before admission
- Patients, who have undertaken cardiac rehab within the 12 months prior to enrollment
- Cognitive, orthopedic or neurological disorders or other impairment which prevents accurate application of intervention or inability to provide informed consent
- End Stage Renal Disease
- Uncontrolled arrhythmia's or 3rd degree AV heart block
- Those with wounds over area of proper placement of electrodes
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04522609
Start Date
September 1 2020
End Date
November 1 2022
Last Update
September 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Institute for Complex Issues of Cardiovascular Diseases
Kemerovo, Russia, 650002